192 related articles for article (PubMed ID: 24476455)
1. Editorial. Molecular image-guided cancer treatment: moving towards personalized medicine--Part I.
Liu Z
Curr Pharm Biotechnol; 2013; 14(7):643. PubMed ID: 24476455
[No Abstract] [Full Text] [Related]
2. Molecular imaging-guided theranostics and personalized medicine.
Zhang H; Tian M; Li E; Fujibayashi Y; Shen LH; Yang DJ
J Biomed Biotechnol; 2012; 2012():747416. PubMed ID: 22851886
[No Abstract] [Full Text] [Related]
3. Editorial.
Baxter G
Clin Radiol; 2017 Jan; 72(1):1-2. PubMed ID: 27836105
[No Abstract] [Full Text] [Related]
4. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.
Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F;
Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744
[TBL] [Abstract][Full Text] [Related]
5. New advance in breast cancer pathology and imaging.
Urbano N; Scimeca M; Bonfiglio R; Bonanno E; Schillaci O
Future Oncol; 2019 Aug; 15(23):2707-2722. PubMed ID: 31339050
[TBL] [Abstract][Full Text] [Related]
6. Molecular image-guided theranostic and personalized medicine 2014.
Zhang H; Tian M; Carrio I; Civelek AC; Fujibayashi Y
Biomed Res Int; 2015; 2015():258612. PubMed ID: 25883947
[No Abstract] [Full Text] [Related]
7. Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy.
Broos K; Lecocq Q; Raes G; Devoogdt N; Keyaerts M; Breckpot K
Theranostics; 2018; 8(13):3559-3570. PubMed ID: 30026866
[TBL] [Abstract][Full Text] [Related]
8. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
[TBL] [Abstract][Full Text] [Related]
9. Nuclear image-guided personalized treatment and prevention of cancers.
Yang DJ; Kong F; Shen LH; Inoue T; Zakko S
Curr Med Chem; 2012; 19(20):3253-4. PubMed ID: 22664240
[No Abstract] [Full Text] [Related]
10. Point: The Imprecise Pursuit of Precision Medicine: Are Biomarkers to Blame?
Gyawali B
J Natl Compr Canc Netw; 2017 Jul; 15(7):859-862. PubMed ID: 28687572
[No Abstract] [Full Text] [Related]
11. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
Saumet A; Lecellier CH
Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
[TBL] [Abstract][Full Text] [Related]
12. Achieving the goals of effective, safe, and individualized cancer care.
Roberts SA; Karnes EK; Allen JD; Benner JS; Sigal EV; McClellan M
Clin Cancer Res; 2011 Nov; 17(21):6632-3. PubMed ID: 22046023
[No Abstract] [Full Text] [Related]
13. Biomarkers, bioindicators, molecular imaging, functional imaging, precision medicine, and the search for intelligent life in the universe.
Schweitzer M
J Magn Reson Imaging; 2016 Jul; 44(1):11. PubMed ID: 27007014
[No Abstract] [Full Text] [Related]
14. Nuclear medicine and anatomic pathology in personalized medicine: a challenging alliance.
Urbano N; Scimeca M; Bonanno E; Schillaci O
Per Med; 2018 Nov; 15(6):457-459. PubMed ID: 30398094
[No Abstract] [Full Text] [Related]
15. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
Browman GP
J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
[No Abstract] [Full Text] [Related]
16. Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
Lütje S; Feldmann G; Essler M; Brossart P; Bundschuh RA
J Nucl Med; 2020 Aug; 61(8):1137-1144. PubMed ID: 31924724
[TBL] [Abstract][Full Text] [Related]
17. Applications of molecular imaging in drug discovery and development process.
Ahn BC
Curr Pharm Biotechnol; 2011 Apr; 12(4):459-68. PubMed ID: 21342108
[TBL] [Abstract][Full Text] [Related]
18. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.
Rajendran JG; Krohn KA
Semin Nucl Med; 2015 Mar; 45(2):151-62. PubMed ID: 25704387
[TBL] [Abstract][Full Text] [Related]
19. [Translational research - towards personalized medicine].
Tokui T
Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):122-5. PubMed ID: 23470475
[No Abstract] [Full Text] [Related]
20. Emerging Biomarkers in the Era of Personalized Cancer Medicine.
Ricciuti B; Leonardi GC; Brambilla M
Dis Markers; 2019; 2019():5907238. PubMed ID: 31485277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
